Conditionally replicating herpes vectors for cancer therapy

[11] Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector [J]. GENE THERAPY, 1998, 5 (06) : 809 - 819

[12] Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation of intracerebral injection in nonhuman primates [J]. JOURNAL OF VIROLOGY, 1999, 73 (08) : 6319 - 6326

[13] Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses [J]. NATURE MEDICINE, 1999, 5 (08) : 881 - 887

[14] Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207) [J]. FASEB JOURNAL, 1999, 13 (11) : 1325 - 1334

[15] Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice [J]. JOURNAL OF NEUROVIROLOGY, 1998, 4 (01) : 100 - 105

[16] MARKERT J, 1998, 23 INT HERP WORKSH Y, pA384

[17] REDUCTION AND ELIMINATION OF ENCEPHALITIS IN AN EXPERIMENTAL GLIOMA THERAPY MODEL WITH ATTENUATED HERPES-SIMPLEX MUTANTS THAT RETAIN SUSCEPTIBILITY TO ACYCLOVIR [J]. NEUROSURGERY, 1993, 32 (04) : 597 - 603

[18] EXPERIMENTAL-THERAPY OF HUMAN GLIOMA BY MEANS OF A GENETICALLY ENGINEERED VIRUS MUTANT [J]. SCIENCE, 1991, 252 (5007) : 854 - 856

[19] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J]. NATURE MEDICINE, 1995, 1 (09) : 938 - 943

[20] MINETA T, 1994, CANCER RES, V54, P3963

[11] Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector [J]. GENE THERAPY, 1998, 5 (06) : 809 - 819

[12] Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation of intracerebral injection in nonhuman primates [J]. JOURNAL OF VIROLOGY, 1999, 73 (08) : 6319 - 6326

[13] Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses [J]. NATURE MEDICINE, 1999, 5 (08) : 881 - 887

[14] Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207) [J]. FASEB JOURNAL, 1999, 13 (11) : 1325 - 1334

[15] Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice [J]. JOURNAL OF NEUROVIROLOGY, 1998, 4 (01) : 100 - 105

[16] MARKERT J, 1998, 23 INT HERP WORKSH Y, pA384

[17] REDUCTION AND ELIMINATION OF ENCEPHALITIS IN AN EXPERIMENTAL GLIOMA THERAPY MODEL WITH ATTENUATED HERPES-SIMPLEX MUTANTS THAT RETAIN SUSCEPTIBILITY TO ACYCLOVIR [J]. NEUROSURGERY, 1993, 32 (04) : 597 - 603

[18] EXPERIMENTAL-THERAPY OF HUMAN GLIOMA BY MEANS OF A GENETICALLY ENGINEERED VIRUS MUTANT [J]. SCIENCE, 1991, 252 (5007) : 854 - 856

[19] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J]. NATURE MEDICINE, 1995, 1 (09) : 938 - 943

[20] MINETA T, 1994, CANCER RES, V54, P3963